Prognostic considerations based on a study of 38 hanseniasis patients submitted to Mitsuda tests 23 to 35 years previously
Vol. 3 No. 1 (1978), Original articles
Vol. 3 No. 1 (1978)

Prognostic considerations based on a study of 38 hanseniasis patients submitted to Mitsuda tests 23 to 35 years previously

Original articles
https://doi.org/10.47878/hi.1978.v3.35636
Published 1978-06-30
MAURICIO M. A. ALCHORNE
Professor of Dermatology, Faculdade de Medicina, Universidade de Mogi das Cruzes, S. Paulo, Brazil. Assistant-Professor of Dermatology, Escola Paulista de Medicina, S. Paulo, Brazil.
ABRAHÃO ROTBERG
Professor of Dermatology, Universidade de S. Paulo, Brazil. Chairman of the Hansenology Committee, S. Paulo State Public Health Service, Brazil.
JORGE MICHALANY
Professor of Pathology, Escola Paulista de Medicina, S. Paulo, Brazil.
PAULO DE O. VARGAS
Head of the Health Unit Lapa, of the S. Paulo State Public Health Service, Brazil.
TUPY P. CASSIANO
Head of the Health Unit Bom Retiro, of the S. Paulo State Public Health Service, Brazil.
PDF

Keywords

Hanseniasis
Mitsuda test
Prognosis
Immunology in hanseniasis

How to Cite

1.
ALCHORNE MMA, ROTBERG A, MICHALANY J, VARGAS PDO, CASSIANO TP. Prognostic considerations based on a study of 38 hanseniasis patients submitted to Mitsuda tests 23 to 35 years previously. Hansen. Int. [Internet]. 1978 Jun. 30 [cited 2024 Nov. 26];3(1):5-11. Available from: https://periodicos.saude.sp.gov.br/hansenologia/article/view/35636
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Out of 2.775 hanseniasis patients Mitsuda tested by one of the authors (R) from 1933 to 1947, 38 were re-examined in 1970/1971. 28 had been treated regularly, 6 did not receive sulfones. Improvement or disappearance of dermatological lesions occurred in 31 (81.5%), independently of reactivity. All eleven bacteriologically positive out of 19 Mitsuda negative patients became bacteriologically negative, which is partly attributed to sulfones. One treated bacillary negative patient became positive. 28 (76,3%) were neurollogically aggravated, independently of reactivity but more evidently among the stronger reactors. As regards classification, all initially "tuberculoid", "Virchowian" and "dimorphous" patients continued in their types or group, but only 7 (41.2%) out of the 17 initially "indetermined" remained so. Four (23.5%) two Mitsuda+ +, two+ changed to reactional tuberculoid, 6 (35,3%) (3 Mitsuda — 2+ and 1+ +) changed to the Virchowian type. These developments according to reactivity confirm the pathogenetic theory postulated in 1937 by one of the authors (R). Mitsuda reactivity remained generally unchanged, rarely increased or decreased. The good prognostic value of the strong Mitsuda test is generally confirmed, but only as regards classification, bacillation and dermatological lesions — not from the neurological and social viewpoints.

https://doi.org/10.47878/hi.1978.v3.35636
PDF

References

1. BASOMBRIO, G.; GATTI, J. C.; CARDAMA, J. E.; COLOMBO, C. V. Modificaciones de la lepromino reacción. Int. J. Lepr., 18(4):481-486, 1950.
2. BASOMBRIO, G.; MOM, A.; GATTI, J. C. Tratamiento de la lepra con la diasona: nuestra experiencia. In: CONGRESO INTERNACIONAL DE LA LEPRA, 5.°, Habana, 1948. Memoria. Habana, Cenit, 1949. p. 169.
3. DHARMENDRA & MUKHERJI, N. Lepromin reaction in subsided lepromatous cases. Lepr. Indian, 19(1) :5-10, 1947.
4. DHARMENDRA & MUKHERJI, N. Prognostic value of the lepromin test. Lepr. India, I8(3): 80-87, Jul. 1946.
5. DHARMENDRA & SANTRA, I. .A study of the course of the disease in leprosy. Lepr. India, 18(2):43-50, 1946.
6. FLOCH, H.Positivation de la lepromino-reaction chez les lépreux indifferenciés traités par les sulf ones. In: CONFERENCIA PANAMERICANA DE LEPROLOGIA, 3.°, Buenos Aires, 1951. Memoria. Buenos Aires, Ministerio de Salud Publica de la Nacion, 1953. v.1, p. 265-269.
7. HAYASHI, F. Mitsuda's skin reaction in leprosy. Int. J. Lepr., 1(1):31-38, 1933.
8. IGARASHI, M. & HAYASHI, F. Observation of patients with atypical Mitsuda reactions, after an interval of ten years.Int. J. Lepr., 8(4):457-464, 1940.
9. IGNACIO, J. L. Observations on the leprolin test in clinically active, bacteriologically positive lepers. Monthly Bull. Bur. Health Phili pp., 19(2):95-105, 1939.
10. KANELE, D. K. Immunological and allergic reactions in the sulphone treatment of leprosy. Coll. Sci. Papers Leprol. Dermatol. (16) :78-82, 1962 apud Lepr. Rev., 34(1):44, 1963.
11. LAGROSA, M. The leprolin (Mitsuda) reaction in "negative" lepers: I. Observations over a period of one years. Monthly Bull. Bur. Health Philipp., 19(2): 83-93, 1939.
12. MARTINEZ DOMINGUEZ, V. Estudio epidemiologico y clinico de la endemia de lepra en la Guinea Espanola. XIII. Influencia de la moderna terapeutica antileprosa sobre la marcha de la endemia. In: CONGRESO INTERNACIONAL DE LEPROLOGIA, 6.°, Madrid, 1953. Memoria. Madrid, Gobierno de Espana, 1954. Item 13, p. 1166-1173.
13. MERKLEN, F. P.; COTTENOT, F.; GHARBI, R. Disparition secondaire de la positivité de la réaction de Mitsuda au cours d'une maladie de Hansen ancienne. Bull. Soc. Franç. Devitt. Syph., 76(3): 297, 1969.
14. QUAGLIATO, R.; MIRANDA, J. R.; REIS FILHO, J. C. M. Recidivas em doentes de lepra considerados curados. Casos do Departamento de Profilaxia da Lepra (S. Paulo), 1939-1960. In: CONGRESSO INTERNACIONAL DE LEPROLOGIA, 8.°, Rio de Janeiro, 1963. Anais. Rio de Janeiro, Serviço Nacional de Lepra, s.d. v.2, p. 360-375.
15. RABELLO, F. E. A doutrina da hanseníase na concepção dos hansenólogos de formação latina (1938-1974): um retrospecto com vistas ao futuro Congresso Internacional - México 1978. (The Latin American conception of hanseniasis - 1938/1974: a retrospect having in view the International Congress, Mexico, 1978). Med. Cut. lb. Lat. Amer., 4:217-226, 1976.
16. RADNA, R. Note sur la réaction de Mitsuda chez des sujets indemnes de lèpre. De l'influence du traitement de la lèpre sur la bacillémie lépreuse et sur les résultats de la reaction de Mitsuda. Ann. Soc. Beige Méd. Trop., 18(1):64-72, 1938.
17. RODRIGUEZ, J. N. Observations on the leprolin (Mitsuda) reaction. Int. 1. Lepr., 6(1): 11-31, 1938.
18. ROTBERG, A. Fator "N" de resistência à lepra e relações com a reatividade lepromínica e tuberculinica. Valor duvidoso do BCG na imunização anti-leprosa. ("N-Fator" of resistance to leprosy and its relationships with reactivity to lepromin and tuberculin. Doubtful
v'alue of BCG ira anti-leprous immunization). Rev. Bras. Leprol., 25:85-106, 1957.
19. ROTBERG, A. The influence of allergic factors in the pathogenesis of leprosy. In: PACIFIC SCIENCE CONGRESS, 6th, Berkeley, Ca., 1939. Proceedings. s.n.t. v. 5, p. 977-982.
20. ROTBERG, A. Modern trends in the study of the epidemiology of leprosy. In: PACIFIC SCIENCE CONGRESS, 6th, Berkeley, 1939. Proceedings. s.n.t. v. 5, p. 939-945.
21. ROTBERG, A. The reading of the lepromin test. Int. I. Lepr., 7:161-166. 1939.
22. ROTBERG, A. Some aspects of immunity in leprosy and their importance in epidemiology, pathogenesis and classification of forms of the disease; based on 1529 lepromin tested cases. Rev. Bras. Leprol., 5(n. esp.):45-97, 1937.
23. ROTBERG, A. Valor prognóstico da lepromino-reação de Mitsuda; observação de 445 casos durante 5-6 anos.Rev. Bras. Leprol., 12(4):367-377, 1944.
24. SATO, S. & FUKUDA, M. Marked increase in Mitsuda positivity in lepromatous cases with reference to clinical features.Int. 1. Lepr., 26(3):205-218, 1958.
25. SCHUJMAN, S. Estudio evolutivo del estado inmunologico en los casos lepromatosos beneficiados con diversos medicamentos antileprosos (Chaulmoogra y sulfonas). In: CONFERENCIA PANAMERICANA DE LEPROLOGIA, 3P, Buenos Aires, 1951. Memoria. Buenos Aires, Ministerio de Salud Publica de la Nacion, 1953. v.1, p. 195-198.
26. SOUZA LIMA, L. & ALAYON, F. L. Sobre a significaçño patológica das lesões incaracterísticas (maculares simples). São Paulo, Departamento de Profilaxia da Lepra, 1941. 301 p.

This journal is licensed under a Creative Commons Attribution 4.0 International License.

Downloads

Download data is not yet available.